Can you get vaccinated while on Cosentyx?
No, vaccinations are not fully restricted while using Cosentyx (secukinumab), but live vaccines are contraindicated. The drug suppresses the immune system by targeting IL-17A, increasing risks from live attenuated vaccines like MMR, varicella, or oral polio. Patients should avoid these during treatment and for several weeks after stopping.[1][2]
Inactivated or recombinant vaccines (e.g., flu shot, COVID-19 vaccines, Tdap) are generally safe and recommended. Guidelines advise completing vaccinations before starting Cosentyx if possible, especially live ones.[1][3]
What does the prescribing information say?
Cosentyx labeling states: "Live vaccines should not be given concurrently with COSENTYX." No broad restriction exists on non-live vaccines. Antibody responses to vaccines may be reduced due to immunosuppression, so timing and boosters matter.[1]
How soon before or after Cosentyx can you vaccinate?
- Avoid live vaccines for at least 4-6 weeks before starting Cosentyx and until 3 weeks after the last dose, per clinical pharmacology data on its half-life (22-31 days).[2]
- Non-live vaccines can be given anytime, but consult a doctor for optimal immune response—some studies show 20-50% lower antibody titers post-treatment.[3]
What about specific vaccines patients worry about?
| Vaccine Type | Safe with Cosentyx? | Notes |
|--------------|---------------------|-------|
| Flu (inactivated) | Yes | Annual shots encouraged; response may be weaker.[1] |
| COVID-19 (mRNA or protein) | Yes | Full series and boosters advised by rheumatology experts.[3] |
| Shingles (Shingrix, recombinant) | Yes | Preferred over live Zostavax.[2] |
| Pneumococcal (PCV13/20, PPSV23) | Yes | Routine for at-risk patients.[1] |
| Live (e.g., yellow fever, nasal flu) | No | Defer until off Cosentyx.[2] |
Does this apply to kids or pregnant patients?
Pediatric labeling mirrors adults: no live vaccines during treatment. Pregnancy registries note no specific vaccine bans, but inactivated ones are preferred. Discuss with providers, as data is limited.[1][4]
Why the live vaccine restriction?
Cosentyx blocks IL-17, impairing immune control of viral replication in live vaccines, risking disseminated infections like varicella.[2]
Sources
[1]: Cosentyx Prescribing Information (Novartis)
[2]: FDA Label for Secukinumab
[3]: ACR Guidelines on Vaccinations in Rheumatic Diseases
[4]: MotherToBaby Fact Sheet on Secukinumab